Keywords
infectious mononucleosis
Epstein-Barr virus
microbial flora
immunity
How to Cite
Abstract
Objective. The article presents the results of studies to determine the significance of the microbial flora of the nasal mucosa and oropharynx in the formation of the clinical course and immune response in children with infectious mononucleosis (IM). Materials and methods. Under the supervision were 93 children aged three to nine years, patients with mononucleosis. In 32 children (first group), Streptococcus pyogenes at concentrations of 10-5 and higher was isolated during bacteriological examination of the mucosa of the nasopharynx and oropharynx. 30 (second group) - 10-4 degrees or less. In 31 (the third group), Staphylococcus aureus, Spirochetae buccalis, E. Coli and other bacteria, except streptococcus, were sown in smears from the mucous membrane of the nasoropharynx. The immune status of patients was assessed by indicators of levels of lymphocytes CD3+, CD4+, CD8+, CD22+ and the content of interleukins 1β, 4, TNFα. Results. The acute period of the mononucleosis in children of the first group was characterized more severe symptoms of intoxication, more severe morphological changes in the tissues of the tonsils, lymph nodes, liver and spleen. Also a significant decrease in the relative amount of CD3+, CD4+, CD8+ was observed compared with the indicators of children of the second and third groups. The increase in blood CD22+ content was more significant in children of the first group. The content of pro-inflammatory IL-1β and TNF-α in patients of all groups was significantly higher than in healthy children. The IL-4 increased in children of the second and third groups. In the period of early convalescence in children of the second and third groups, the relative content of CD3+, CD4+, CD8+ cells approached the corresponding indices of the control group. This was not observed in children of the first group. CD22+ levels in all observation groups decreased by the convalescence period, but remained high compared with the control group. In children of the studied groups, by the period of reconvalescence, a decrease in the levels of IL-1β, TNF-α is noted, more significant in children of the second and third groups. At the same time, in children of the first group, the level of pro-inflammatory interleukins by the period of reconvalescence remained at high numbers. The content of IL-4 was a significant difference in the indicators of its content in comparison with the digital characteristics of healthy ones in children of the second and third groups. Conclusion. An analysis of the results of the study found that the presence of streptococcus in its high concentration on the mucosa of the nosopharynx of children with mononucleosis already contributes to the formation of cellular immunosuppression and a pronounced reaction of pro-inflammatory interleukins at the initial stage of the disease, which, in general, leads to aggravation of the clinical manifestations of the disease and, in our opinion, may be a causative factor of a possible unfavorable course of the disease.
References
Krasnov, M. V., Stekolschikova, I. A., Borovkova, M.G., Andreeva, L. V. (2015). Zhurnal: sovremennyie problemyi nauki i obrazovaniya. Infektsionnyiy mononukleoz u detey, 2, 63.
Dunmire , S. K., Hogquist , K. A., Balfour , H. H. (2015). Curr Top Microbiol Immunol. Infectious Mononucleosis, 1, 211–40.
Azzi, T, Luneman, N. A., Murer, A., Ueda, S., Beziat, V, Malmberg, K. J., Staubli, G., Gysin, C., Berger, C., Munz C, Chijioke, O., Nadal, D. (2014). Role for early-differentiated natural killer cells in infectious mononucleosis. Blood, 124, 2533–2543. doi: 10.1182/blood-2014-01-553024.
Bartlett, A., Williams, R., Hilton, M. (2016). Splenic rupture in infectious mononucleosis: A systematic review of published case reports. Injury, 3, 531–538.
Bobruk, S. V. (2017). The degree of indicators level violation of local immunity in children with infectious mononucleosis. Journal of Education, Health and Sport, 3, 576–585.
Chijioke, O., Muller, A., Feederle, R., Barros, M. H., Krieg, C., Emmel, V, Marcenar, O. E., Leung, C. S., Antsiferova, O., Landtwing, V, Bossar. t, W, Morett. a, A., Hassan, R., Boyman, O., Niedobitek, G., Delecluse, H.J, et al. (2013). Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection. Cell Rep., 5, 1489–1498. doi: 10.1016/j.celrep.2013.11.041.
Nicholas John Bennett (2018). Pediatric Mononucleosis and Epstein-Barr Virus Infection. Retrieved from: https://emedicine.medscape.com/article/963894-overview.
Harley, J. B., Chen, X., Pujato, M., Miller, D., Maddox, A., Forney, C., et al. (2018). Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat Genet, 50(5), 699–707.
Huang ,W., Lv, N., Ying, J., Qiu, T., Feng, X. (2014). Clinicopathological characteristics of four cases of EBV positive T-cell lymphoproliferative disorders of childhood in China. Int. J. Clin. Exp. Pathol, 7(8), 4991–4999.
Kessenich , C. R., Flanagan M. (2015). Diagnosis of infectious mononucleosis. Nurse Pract, 40(8), 13–14, 16.
Cunha, B. A., Petelin, A., George, S. (2013). Fever of unknown origin (FUO) in an elderly adult due to Epstein-Barr virus (EBV) presenting as "typhoidal mononucleosis", mimicking a lymphoma. Heart Lung, 42(1), 79–81.
Engelmann, I., Nasser, H., Belmiloudi, S., et al. (2013). Clinically severe Epstein-Barr virus encephalitis with mild cerebrospinal fluid abnormalities in an immunocompetent adolescent: a case report. Diagn Microbiol Infect Dis, 76(2), 232–234.
Kuzembayeva, M., Hayes, M., Sugden, B. (2014). Multiple functions are mediated by the miRNAs of Epstein-Barr virus. Curr Opin Virol, 7, 61–65. doi: 10.1016/j.coviro.2014.04.003.
Langer-Gould, A., Wu, J., Lucas, R., Smith, J., Gonzales, E., Amezcua, L., et al. (2017). Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study. Neurology, 89(13), 1330–1337.
Rickinson, A.B., Fox, C.P. (2013). Epstein-barr virus and infectious mononucleosis: what students can teach us. Infect Dis, 207(1), 6–8.
Leskowitz, R., Fogg, M. H., Zhou, X. Y, Kau. r, A., Silveira, E. L., Villinger, F, Lieberman, P. M., et al. (2014). Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques. Virol, 88, 4721–4735. doi: 10.1128/JVI.03744-13.
Michael, S. (2018). Mononucleosis in Emergency Medicine. Retrieved from: https://emedicine.medscape.com/article/784513-overview.
Styczynski, J., van der Velden, W, Fo. x, C. P, et al. (2016). Management of Epstein-Barr Virus. infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation. Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines. Haematologica, 101(7), 803–811.
Rostgaard, K., Wohlfahrt, J., Hjalgrim, H. (2014). A genetic basis for infectious mononucleosis: evidence from a family study of hospitalized cases in Denmark. Clin Infect Dis, 58(12), 1684–1689.
Zhou, C., Xie, Z., Gao, L., Liu, C., Ai, J., Zhang, L., et al. (2015). Profiling of EBV-Encoded microRNAs in EBV-Associated Hemophagocytic Lymphohistiocytosis. Tohoku J Exp Med, 237, 117–126. doi: 10.1620/tjem.237.117.
Ali, A. S., Al-Shraim, M., Al-Hakami, A. M., Jones, I. M. (2015). Epstein-Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis. Open Virol J, 9, 7–28.
Okano, M., Gross, T. G. (2012). Acute or chronic life-threatening diseases associated with EpsteinBarr virus infection. Am J Med Sci, 343(6), 483-9.
"Inter Collegas" is an open access journal: all articles are published in open access without an embargo period, under the terms of the CC BY-NC-SA (Creative Commons Attribution ‒ Noncommercial ‒ Share Alike) license; the content is available to all readers without registration from the moment of its publication. Electronic copies of the archive of journals are placed in the repositories of the KhNMU and V.I. Vernadsky National Library of Ukraine.
Copyright Agreement
1. This Agreement on the transfer of rights to use the work from the Co-authors to the publisher (hereinafter the Agreement) is concluded between all the Co-authors of the work, represented by the Corresponding Author, and Kharkiv National Medical University (hereinafter the University), represented by an authorized representative of the Editorial Board of scientific journals (hereinafter the Editorial Board).
2. This Agreement is an accession agreement within the meaning of clause 1 of Article 634 of the Civil Code of Ukraine: that is, a contract, "the terms of which are established by one of the parties in forms or other standard forms, which can be concluded only by joining the other party to the proposed contract as a whole. The other party cannot offer its terms of the contract." The party that established the terms of this contract is the University.
3. If there is more than one author, the authors choose the Corresponding Author, who communicates with the Editorial Board on his own behalf and on behalf of all Co-authors regarding the publication of a written work of a scientific nature (article or review, hereinafter referred to as the Work).
4. The contract begins from the moment of submission of the manuscript of the Work by the Corresponding Author to the Editorial Board, which confirms the following:
4.1. all Co-authors of the Work are familiar with and agree with its content, at all stages of reviewing and editing the manuscript and the existence of the published Work;
4.2. all Co-authors of the Work are familiar with and agree to the terms of this Agreement.
5. The published Work is in electronic form in public access on the websites of the University and any websites and electronic databases in which the Work is posted by the University and is available to readers under the terms of the "Creative Commons" license (Attribution NonCommercial Sharealike 4.0 International)" or more free licenses "Creative Commons 4.0".
6. The Corresponding Author transfers, and the University receives, the non-exclusive property right to use the Work by placing the latter on the University's websites for the entire term of copyright. The University participates in the creation of the final version of the Work by reviewing and editing the manuscript of the article or review provided to the Editorial Board by the Corresponding Author, translating the Work into any languages. For the participation of the University in the finalization of the Work, the Co-authors agree to pay the invoice issued to them by the University, if such payment is provided by the University. The size and procedure of such payment are not the subject of this contract.
7. The University has the right to reproduce the Work or its parts in electronic and printed forms, to make copies, permanent archival storage of the Work, distribution of the Work on the Internet, repositories, scientometric databases, commercial networks, including for monetary compensation from third parties.
8. The co-authors guarantee that the manuscript of the Work does not use works whose copyright belongs to third parties.
9. The authors of the Work guarantee that at the time of submission of the manuscript of the Work to the Editorial Board, the property rights to the Work belong only to them, neither in whole nor in part have they been transferred to anyone (not alienated), they are not the subject of a lien, litigation or claims by third parties.
10. The Work may not be posted on the University's website if it violates a person's right to the privacy of his personal and family life, harms public order and health.
11. The work may be withdrawn by the Editorial Board from the University websites, libraries and electronic databases where it was placed by the Editorial Board, in cases of detection of violations of the ethics of the authors and researchers, without any compensation for the losses of the Co-authors. At the time of submission of the manuscript to the Editorial Board and all stages of its editing and review, the manuscript must not have already been published or submitted to other editorial offices.
12. The right transferred under this Agreement extends to the territory of Ukraine and foreign countries.
13. The rights of Co-authors include the requirement to indicate their names on all copies of the Work or during any public use or public mention of the Work; the requirement to preserve the integrity of the Work; legal opposition to any distortion or other encroachment on the Work, which may harm the honor and reputation of the Co-authors.
14. Co-authors have the right to control their personal non-property rights by familiarizing themselves with the text (content) and form of the Work before its publication on the University's website, when transferring it to a printing company for reproduction or when using the Work in other ways.
15. The Co-authors, in addition to the property rights not transferred under this Agreement and taking into account the non-exclusive nature of the rights transferred under this Agreement, retain the property rights to finalize the Work and to use certain parts of the Work in other works created by the Co-authors.
16. The Co-authors are obliged to notify the Editorial Board of all errors in the Work, discovered by them independently after the publication of the Work, and to take all measures to eliminate such errors as soon as possible.
17. The University undertakes to indicate the names of the Co-authors on all copies of the Work during any public use of the Work. The list of Co-authors may be shortened according to the rules for the formation of bibliographic descriptions determined by the University or third parties.
18. The University undertakes not to violate the integrity of the Work, to agree with the Corresponding Author on all changes made to the Work during processing and editing.
19. In case of violation of their obligations under this Agreement, its parties bear the responsibility defined by this Agreement and the current legislation of Ukraine. All disputes under the Agreement are resolved through negotiations, and if the negotiations do not resolve the dispute – in the courts of the city of Kharkiv.
20. The parties are not responsible for the violation of their obligations under this Agreement, if it occurred through no fault of theirs. The party is considered innocent if it proves that it has taken all measures dependent on it for the proper fulfillment of the obligation.
21. The Co-authors are responsible for the truthfulness of the facts, quotes, references to legislative and regulatory acts, other official documentation, the scientific validity of the Work, all types of responsibility to third parties who have claimed their rights to the Work. The co-authors reimburse the University for all costs caused by claims of third parties for infringement of copyright and other rights to the Work, as well as additional material costs related to the elimination of identified defects.